Rozlytrek 50 mg film coated granules in sachet
*Company:
Roche Registration GmbHStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
This medicinal product is subject to additional monitoring.
*Additional information is available within the SPC or upon request to the company

Updated on 01 April 2025
File name
ROZ_PSUSA_granules_PIL_24Mar2025.pdf
Reasons for updating
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
- Change to information for healthcare professionals
Updated on 01 April 2025
File name
ROZ_PSUSA_granules_PIL_24Mar2025.pdf
Reasons for updating
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
- Change to information for healthcare professionals
Updated on 01 April 2025
File name
ROZ_PSUSA_granules_PIL_24Mar2025.pdf
Reasons for updating
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
- Change to information for healthcare professionals
Updated on 01 April 2025
File name
ROZ_PSUSA_granules_PIL_24Mar2025.pdf
Reasons for updating
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
- Change to information for healthcare professionals
Updated on 01 April 2025
File name
ROZ_PSUSA_granules_PIL_24Mar2025.pdf
Reasons for updating
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
- Change to information for healthcare professionals
Updated on 01 April 2025
File name
ROZ_PSUSA_granules_SmPC_24Mar2025.pdf
Reasons for updating
- Change to section 4.8 - Undesirable effects
- Change to section 9 - Date of first authorisation/renewal of the authorisation
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 03 July 2024
File name
ROZ_II17G_Granules_SmPC_dated 27Jun2024.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 03 July 2024
File name
ROZ_II17G_Granules_PIL_dated 27Jun2024.pdf
Reasons for updating
- New PIL for new product
Roche Registration GmbH

Address:
3004 Lake Drive, Citywest, Naas Road, Dublin 24Medical Information E-mail:
ireland.druginfo@roche.comTelephone:
+353 1 469 0700Fax:
+353 1 469 0791